Research output per year
Research output per year
Personal profile
Headline
ASSOCIATE CLINICAL PROFESSOR
Biography
Certifications American Board of Dermatology Education MD, SUNY at Stony Brook School of Medicine Internship, Internal Medicine, Westchester Medical Center Residency, Dermatology, S.U.N.Y Health Science Center - College of Medicine Fellowship, MOHS Surgery, University of Wisconsin Hospital
Fingerprint
Dive into the research topics where Leon Kircik is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Breaking the Frustrating Cycle of Topical Steroids in Psoriasis: A Review of a Novel Vehicle for Fixed-Dose Combination Halobetasol Propionate/Tazarotene
Kircik, L., Bhatia, N., Lain, E. & Jacobson, A., 1 Mar 2023, In: Journal of Drugs in Dermatology. 22, 3, p. 247-251 5 p.Research output: Contribution to journal › Review article › peer-review
-
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial
Strober, B., Thaçi, D., Sofen, H., Kircik, L., Gordon, K. B., Foley, P., Rich, P., Paul, C., Bagel, J., Colston, E., Throup, J., Kundu, S., Sekaran, C., Linaberry, M., Banerjee, S. & Papp, K. A., Jan 2023, In: Journal of the American Academy of Dermatology. 88, 1, p. 40-51 12 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b Trial
Stein Gold, L., Alonso-Llamazares, J., Draelos, Z. D., Gooderham, M. J., Kempers, S. E., Kircik, L. H., Lebwohl, M. G., Papp, K. A., Pariser, D. M., Toth, D. P., Yosipovitch, G., Higham, R. C., Feng, A. & Berk, D. R., Mar 2023, In: American Journal of Clinical Dermatology. 24, 2, p. 305-313 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Efficacy and safety of etrasimod, a sphingosine 1-phosphate receptor modulator, in adults with moderate-to-severe atopic dermatitis (ADVISE)
Silverberg, J. I., Bissonnette, R., Kircik, L., Murrell, D. F., Selfridge, A., Liu, K., Ahluwalia, G. & Guttman-Yassky, E., 2023, (Accepted/In press) In: Journal of the European Academy of Dermatology and Venereology.Research output: Contribution to journal › Article › peer-review
Open Access -
Improvements in acne and skin oiliness with tazarotene 0.045% lotion in patients with oily skin
Tanghetti, E. A., Zeichner, J. A., Gold, M., Sadick, N., Cook-Bolden, F. E., Kircik, L. H., Stein Gold, L., Weiss, J., Tyring, S. K., Del Rosso, J. Q. & Guenin, E., 2023, In: Journal of Dermatological Treatment. 34, 1, 2147391.Research output: Contribution to journal › Article › peer-review
Open Access
Press/Media
-
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.
6/10/22
1 item of Media coverage
Press/Media
-
Study Suggests Roflumilast May Be Effective As Treatment For Plaque Psoriasis
20/09/22
2 items of Media coverage
Press/Media
-
Roflumilast foam efficacy in seborrheic dermatitis spans race, ethnicity
16/09/22
1 item of Media coverage
Press/Media
-
Tapinarof Cream Benefits Psoriasis Regardless of Baseline Disease Severity, Duration
2/07/22
2 items of Media coverage
Press/Media